Nerve ablation for heart failure with reduced pumping strength
Part of Heart & circulation clinical trials.
This trial tests a procedure that uses a catheter to ablate a nerve in the abdomen to treat chronic heart failure. It may help patients with reduced ejection fraction who still have symptoms despite standard medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic heart failure and take water pills for your symptoms.
- Your heart's pumping strength (ejection fraction) is between 20% and 40%.
- You are at least 40 years old.
- You have been on stable heart failure medications for at least 30 days.
- You have not had a heart attack or heart procedure in the past 3 months.
- You are able to walk at least 100 meters but not more than 450 meters in 6 minutes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a procedure that calms overactive kidney nerves (renal denervation) can improve symptoms and heart function in people with heart failure with preserved ejection fraction. It also checks that the kidney arteries are suitable and that your blood pressure and heart pressure measurements meet the study targets.
This trial tests a procedure to “turn off” the right greater splanchnic nerve to improve symptoms in people with HFpEF (heart failure with preserved pumping function). If successful, it may reduce shortness of breath and fluid congestion in daily life.
This trial tests whether a minimally invasive procedure called renal denervation—which reduces nerve activity in blood vessels near the kidneys—can help people with heart failure feel better and exercise with less shortness of breath. You would receive this procedure in addition to your regular heart failure medications.
This trial tests a nerve block procedure to improve heart function in people with heart failure and reduced pumping ability. It aims to see if blocking certain nerves can help you feel better and be more active.
This trial tests a device that uses a catheter to deliver energy to nerves around the pulmonary arteries, aiming to reduce high blood pressure in the lungs caused by left heart failure. It is for people with ongoing heart failure symptoms despite optimal medications.
This trial tests a procedure called pulmonary artery denervation for people with heart failure who still have a normal pumping ability. It aims to improve symptoms like shortness of breath and reduce fluid buildup.
Hear when a new Heart Failure With Reduced Ejection Fraction (HFrEF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.